XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 8,735 $ 7,244
General and administrative 4,561 2,179
Total operating expenses 13,296 9,423
Loss from operations (13,296) (9,423)
Other income (expense):    
Interest income 11 50
Other (expense) income, net (13) 167
Total other (expense) income, net (2) 217
Loss before income tax expense (13,298) (9,206)
Income tax expense (39)  
Net loss (13,337) (9,206)
Net loss attributable to non-controlling interest   (205)
Net loss attributable to common stockholders $ (13,337) $ (9,001)
Net loss per share attributable to common stockholders, basic and diluted $ (0.88) $ (41.69)
Weighted average common stock outstanding, basic and diluted 15,160,046 215,890
Other comprehensive loss:    
Net loss $ (13,337) $ (9,206)
Unrealized loss on available-for-sale securities, net of tax (43)  
Foreign exchange translation adjustment, net of tax (65) (176)
Comprehensive loss (13,445) (9,382)
Less: Comprehensive loss attributable to non-controlling interest   (205)
Comprehensive loss attributable to common stockholders $ (13,445) $ (9,177)